181 related articles for article (PubMed ID: 24159006)
21. Continuous glucose monitoring in people with diabetes: the randomized controlled Glucose Level Awareness in Diabetes Study (GLADIS).
New JP; Ajjan R; Pfeiffer AF; Freckmann G
Diabet Med; 2015 May; 32(5):609-17. PubMed ID: 25661981
[TBL] [Abstract][Full Text] [Related]
22. Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes.
Rosenstock J; Cappelleri JC; Bolinder B; Gerber RA
Diabetes Care; 2004 Jun; 27(6):1318-23. PubMed ID: 15161782
[TBL] [Abstract][Full Text] [Related]
23. Web-based guided insulin self-titration in patients with type 2 diabetes: the Di@log study. Design of a cluster randomised controlled trial [TC1316].
Roek MG; Welschen LM; Kostense PJ; Dekker JM; Snoek FJ; Nijpels G
BMC Fam Pract; 2009 Jun; 10():40. PubMed ID: 19508712
[TBL] [Abstract][Full Text] [Related]
24. Insulin glargine in the treatment of type 1 and type 2 diabetes.
Barnett AH
Vasc Health Risk Manag; 2006; 2(1):59-67. PubMed ID: 17319470
[TBL] [Abstract][Full Text] [Related]
25. An Evolutionary Perspective on Basal Insulin in Diabetes Treatment: Innovations in Insulin: Insulin Degludec U-100 and U-200.
Philis-Tsimikas A
J Fam Pract; 2016 Oct; 65(10 Suppl):S14-S22. PubMed ID: 27846338
[TBL] [Abstract][Full Text] [Related]
26. Subcutaneous injection of hyaluronidase with recombinant human insulin compared with insulin lispro in type 1 diabetes.
Garg SK; Buse JB; Skyler JS; Vaughn DE; Muchmore DB
Diabetes Obes Metab; 2014 Nov; 16(11):1065-9. PubMed ID: 24840317
[TBL] [Abstract][Full Text] [Related]
27. [Control of diabetes mellitus].
Daweke H
Verh Dtsch Ges Inn Med; 1990; 96():175-82. PubMed ID: 2092437
[No Abstract] [Full Text] [Related]
28. Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes.
Lteif AN; Schwenk WF
Diabetes Care; 1999 Jan; 22(1):137-40. PubMed ID: 10333915
[TBL] [Abstract][Full Text] [Related]
29. A new experience for incorrect insulin administration.
Kirac CO; Ipekci SH; Kebapcilar L
Acta Diabetol; 2018 Sep; 55(9):985-986. PubMed ID: 29934655
[No Abstract] [Full Text] [Related]
30. Using new insulin strategies in the outpatient treatment of diabetes: clinical applications.
DeWitt DE; Dugdale DC
JAMA; 2003 May; 289(17):2265-9. PubMed ID: 12734138
[TBL] [Abstract][Full Text] [Related]
31. Should the target A1C level be less than 7 percent? Yes: This should be the target for most patients.
Peterson K
Am Fam Physician; 2012 Dec; 86(12):1-2. PubMed ID: 23316992
[No Abstract] [Full Text] [Related]
32. Role of subcutaneous insulin management protocols and order sets in inpatient diabetes management.
Houlden RL; Moore S; Cornish W; Tiwana K
Can J Diabetes; 2014 Apr; 38(2):101-17. PubMed ID: 24690505
[No Abstract] [Full Text] [Related]
33. Standardized modulation of the injection site allows for insulin dose reduction without deterioration of metabolic control.
Pfützner A; Dissel S; Forkel C; Grenningloh M; Bitton G; Nagar R; Forst T
Curr Med Res Opin; 2014 Oct; 30(10):2001-8. PubMed ID: 24940825
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a Conservative Pharmacist-led U-500R Insulin Management Protocol in the Primary Care Setting.
Dumont C; Fitzgerald L; Valdez CA
J Prim Care Community Health; 2020; 11():2150132720973827. PubMed ID: 33218271
[TBL] [Abstract][Full Text] [Related]
35. Exubera inhaled insulin in patients with type 1 and type 2 diabetes: the first 12 months.
Alabraba V; Farnsworth A; Leigh R; Dodson P; Gough SC; Smyth T
Diabetes Technol Ther; 2009 Jul; 11(7):427-30. PubMed ID: 19580355
[TBL] [Abstract][Full Text] [Related]
36. Insulin administration.
American Diabetes Association.
Diabetes Care; 2001 Nov; 24(11):1984-7. PubMed ID: 11679469
[No Abstract] [Full Text] [Related]
37. Treatment Patterns and Outcomes, Before and After Humulin R U-500 Initiation, Among High-Dose Type 2 Diabetes Mellitus Patients in the United States.
Hood RC; Borra S; Fan L; Pollom RD; Huang A; Chen J
Endocr Pract; 2021 Aug; 27(8):798-806. PubMed ID: 34089876
[TBL] [Abstract][Full Text] [Related]
38. [HbA1c is too high despite tablets. With single injections toward better blood glucose values].
MMW Fortschr Med; 2004 Mar; 146(10):43. PubMed ID: 15347083
[No Abstract] [Full Text] [Related]
39. Flexibly timed once-daily dosing with degludec: a new ultra-long-acting basal insulin.
Josse RG; Woo V
Diabetes Obes Metab; 2013 Dec; 15(12):1077-84. PubMed ID: 23577589
[TBL] [Abstract][Full Text] [Related]
40. [Insulin therapy in patients with type 2 diabetes].
Siegmund T; Schumm-Draeger PM
MMW Fortschr Med; 2008 May; 150(18):32-5; quiz 36. PubMed ID: 18533606
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
